Mary Kay Fenton - Net Worth and Insider Trading
Mary Kay Fenton Net Worth
The estimated net worth of Mary Kay Fenton is at least $16,900 dollars as of 2024-04-26. Mary Kay Fenton is the CFO of Achillion Pharmaceuticals Inc and owns about 2,500 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $16,900. Details can be seen in Mary Kay Fenton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mary Kay Fenton has not made any transactions after 2016-12-05 and currently still holds the listed stock(s).
Transaction Summary of Mary Kay Fenton
Mary Kay Fenton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mary Kay Fenton owns 3 companies in total, including Oncorus Inc (ONCR) , Achillion Pharmaceuticals Inc (ACHN) , and Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Mary Kay Fenton’s form 4 insider trades.
Insider Ownership Summary of Mary Kay Fenton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-01 | director |
| ACHN | Achillion Pharmaceuticals Inc | 2018-02-09 | Chief Financial Officer |
| TALS | Talaris Therapeutics Inc | 2021-05-06 | Chief Financial Officer |
Mary Kay Fenton Latest Holdings Summary
Mary Kay Fenton currently owns a total of 1 stock. Mary Kay Fenton owns 2,500 shares of Achillion Pharmaceuticals Inc (ACHN) as of December 5, 2016, with a value of $16,900.
Latest Holdings of Mary Kay Fenton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2016-12-05 | 2,500 | 6.76 | 16,900 |
Holding Weightings of Mary Kay Fenton
Mary Kay Fenton Form 4 Trading Tracker
According to the SEC Form 4 filings, Mary Kay Fenton has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the acquisition of 2,500 shares on December 5, 2016, which cost Mary Kay Fenton around $10,275.
Insider Trading History of Mary Kay Fenton
- 1
Mary Kay Fenton Trading Performance
GuruFocus tracks the stock performance after each of Mary Kay Fenton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mary Kay Fenton is -2.86%. GuruFocus also compares Mary Kay Fenton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mary Kay Fenton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mary Kay Fenton's insider trading performs compared to the benchmark.
Performance of Mary Kay Fenton
Average Return
-28.33%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.29 | -2.86 | 14.29 | -28.33 | -15.36 | 13.56 |
| Relative Return to S&P 500(%) | 1.37 | -10.95 | 3.79 | -47.6 | -26.04 | 1.32 |
Mary Kay Fenton Ownership Network
Ownership Network List of Mary Kay Fenton
Ownership Network Relation of Mary Kay Fenton
Mary Kay Fenton Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Mary Kay Fenton is the director of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
Over the past 18 months, Mary Kay Fenton made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
Mary Kay Fenton Mailing Address
Above is the net worth, insider trading, and ownership report for Mary Kay Fenton. You might contact Mary Kay Fenton via mailing address: Achillion Pharmaceuticals, 300 George Street, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
